Edana Mann, MD

The physicians in our practice are specialists in the diagnosis and treatment of cancer, blood disorders, thrombosis and related genetic disorders. Our physicians, nurse practitioners, nurses, and office personnel work closely with you and your family doctor to provide you with the best in medical care and personal attention. The physicians in our practice are specialists in the diagnosis and treatment of cancer, blood disorders, thrombosis and related genetic disorders. Our physicians, nurse practitioners, nurses, and office personnel work closely with you and your family doctor to provide you with the best in medical care and personal attention. We have moved to a larger new suite in the expanded Helen F. Graham Cancer Center We are proud to announce the addition of our 8th physician. CANCER Our board-certified physicians in Hematology and Oncology, have trained and held faculty positions in nationally and internationally recognized academic centers. Our physicians have experience in the diagnosis and treatment of malignant disorders of the blood and solid organs such as leukemia, lymphomas, and breast cancer. We are major contributors to National Cancer Institute sponsored clinical trials. BLOOD DISORDERS Our physicians have experience in the diagnosis and treatment of diseases of the bone marrow blood count factory, excessive bleeding tendencies bleeding disorders such as hemophilia, and excessive blood clotting thrombosis. Our physicians have organized and directed nationally and locally funded hemophilia programs, participated in clinical trials for the treatment and prevention of thrombosis, and have conducted basic research in understanding how blood coagulation factors ingredients function. TRANSFUSION MEDICINE Our physicians have expertise in the use of and risks of blood transfusion and therapeutic pheresis [blood component extraction for treatment purposes]. Our physician is board-certified in transfusion medicine by the American

Dr. Gerald Raymond is a clinical geneticist and neurologist at Johns Hopkins where he is also a professor of genetic medicine and neurology. He obtained his MD at the University of Connecticut and was trained in Pediatrics at Johns Hopkins Hospital and Neurology at the Mass. General Hospital. He received additional training in developmental neuropathology at the Universite Catholique de Louvain in Belgium and clinical genetics at the Harvard Program. Dr. Raymond’s research has been at the overlap of genetics and neurology with specific focus on peroxisomal disorders including adrenoleukodystrophy. He has been actively involved in newborn screening for ALD and in developing clinical follow-up programs. He has extensive experience in clinical management of neurogenetic issues including peroxisomal and lysosomal disorders. He presently serves as the Director of the Lysosomal Storage Disease program in the department of Genetic Medicine.

Dr. Jill A. Fahrner is an assistant professor in the Departments of Genetic Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her area of clinical expertise is medical genetics. Dr. Fahrner earned her Ph.D. from Johns Hopkins University and her M.D. from the University of North Carolina. She completed pediatrics residency training at Duke University Medical Center. She joined the McKusick-Nathans Institute of Genetic Medicine as a genetic medicine resident in 2009 and completed her training in 2012. She stayed on as chief resident from 2012-2013 and then joined the faculty as an assistant professor in the Department of Pediatrics within the McKusick-Nathans Institute of Genetic Medicine in 2013. Her current primary appointment is Assistant Professor in the Department of Genetic Medicine, where she is Director of the multidisciplinary Epigenetics and Chromatin Clinic.She is a physician-scientist with a long-standing interest in epigenetic mechanisms of disease. Her clinical focus is on caring for individuals with epigenetic and chromatin disorders, specifically Mendelian disorders of the epigenetic machinery, or chromatin modifying disorders. She has seen hundreds of individuals with congenital disorders involving disrupted epigenetics, most of which exhibit neurodevelopmental disabilities and abnormal growth. Her laboratory research is focused on understanding disease mechanisms and developing therapies for select Mendelian disorders of the epigenetic machinery.She is a member of the American Society of Human Genetics (ASHG), having won an ASHG Reviewer’s Choice Abstract Award for her work on growth retardation in Kabuki syndrome 1. She has received a Johns Hopkins School of Medicine Clinician Scientist Award, a Johns Hopkins School of Medicine Musculoskeletal Pilot and Feasibility Award, a William and Ella Owens Medical Research Foundation Award, the Margaret Ellen Nielsen Fellowship Award, and the Alice and YT Chen Travel Award while at Johns Hopkins. She is the recipient of a prestigious Hartwell Foundation Individual Biomedical Research Award and also has ongoing research funding from the National Institutes of Health.